[1]
|
Guyatt, G.H., Akl, E.A., Crowther, M., Gutterman, D.D. and Schuunemann, H.J. (2012) Executive Summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed.: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141, 7S-47S.
|
[2]
|
Wiesner, C. (2001) Arzneimittelsicherheit in der Perihospitalphase—Eine patientenbezogene Analyse des Pharmakotherapieprozesses. Ph.D. Thesis, University of Basel, Basel.
|
[3]
|
Hepler, C.D. and Strand, L.M. (1990) Opportunities and Responsibilities in Pharmaceutical Care. American Journal of Hospital Pharmacy, 47, 533-543.
|
[4]
|
Frokjaer, B., Sondergaard, B. and Herborg, H. (2004) Evidence Report 3—Follow-Up on Outcomes of Drug Therapy (Pharmaceutical Care). Pharmakon, 1-16.
|
[5]
|
Blenkinsopp, A. and Hassey, A. (2005) Effectiveness and Acceptability of Community Pharmacy-Based Interventions in Type 2 Diabetes: A Critical Review of Intervention Design, Pharmacist and Patient Perspectives. International Journal of Pharmacy Practice, 13, 231-240. http://dx.doi.org/10.1211/ijpp.13.4.0001
|
[6]
|
Roughead, E.E., Semple, S.J. and Vitry, A.I. (2005) Pharmaceutical Care Services: A Systematic Review of Published Studies, 1990 to 2003, Examining Effectiveness in Improving Patient Outcomes. International Journal of Pharmacy Practice, 13, 53-70. http://dx.doi.org/10.1211/0022357055551
|
[7]
|
Machado, M., Bajcar, J., Guzzo, G.C. and Einarson, T.R. (2007) Sensitivity of Patient Outcomes to Pharmacist Interventions. Part II: Systematic Review and Meta-Analysis in Hypertension Management. The Annals of Pharmacotherapy, 41, 1770-1781. http://dx.doi.org/10.1345/aph.1K311
|
[8]
|
Machado, M., Bajcar, J., Guzzo, G.C. and Einarson, T.R. (2007) Sensitivity of Patient Outcomes to Pharmacist Interventions. Part I: Systematic Review and Meta-Analysis in Diabetes Management. The Annals of Pharmacotherapy, 41, 1569-1582. http://dx.doi.org/10.1345/aph.1K151
|
[9]
|
Machado, M., Nassor, N., Bajcar, J.M., Guzzo, G.C. and Einarson, T.R. (2008) Sensitivity of Patient Outcomes to Pharmacist Interventions. Part III: Systematic Review and Meta-Analysis in Hyperlipidemia Management. The Annals of Pharmacotherapy, 42, 1195-1207. http://dx.doi.org/10.1345/aph.1K618
|
[10]
|
Wubben, D.P. and Vivian, E.M. (2008) Effects of Pharmacist Outpatient Interventions on Adults with Diabetes Mellitus: A Systematic Review. Pharmacotherapy, 28, 421-436. http://dx.doi.org/10.1592/phco.28.4.421
|
[11]
|
Miller, N.H., Hill, M., Kottke, T. and Ockene, I.S. (1997) The Multilevel Compliance Challenge: Recommendations for a Call to Action. A Statement for Healthcare Professionals. Circulation, 95, 1085-1090. http://dx.doi.org/10.1161/01.CIR.95.4.1085
|
[12]
|
Haynes, R.B., Ackloo, E., Sahota, N., McDonald, H.P. and Yao, X. (2008) Interventions for Enhancing Medication Adherence. Cochrane Database of Systematic Reviews, 2, CD000011.
|
[13]
|
Mengiardi, S., Goepfert, B., Tsakiris, D.A. and Hersberger, K.E. (2009) Pitfalls in Patient Self-Management of Subcutaneous Drug Application: Removal of Rubber Protection Caps from Ready-to-Use Syringes. European Journal of Clinical Pharmacology, 65, 1061-1062. http://dx.doi.org/10.1007/s00228-009-0681-0
|
[14]
|
Mengiardi, S., Tsakiris, D.A., Lampert, M.L. and Hersberger, K.E. (2011) Drug Use Problems with Self-Injected Low-Molecular-Weight Heparins in Primary Care. European Journal of Clinical Pharmacology, 67, 109-120. http://dx.doi.org/10.1007/s00228-010-0956-5
|
[15]
|
Karch, A.M. (2004) A Needling Problem. American Journal of Nursing, 104, 81-83. http://dx.doi.org/10.1097/00000446-200404000-00026
|
[16]
|
Colwell, C.W., Pullido, P., Hardwick, M.E. and Morris, B.A. (2005) Patient Compliance with Outpatient Prophylaxis: An Observational Study. Orthopedics, 28, 143-147.
|
[17]
|
Spahn, G. (2002) Compliance with Self-Administration of Heparin Injections in Outpatients. European Journal of Trauma and Emergency Surgery, 28, 104-109. http://dx.doi.org/10.1007/s00068-002-1176-1
|
[18]
|
Watts, A.C., Howie, C.R. and Simpson, A.H. (2006) Assessment of a Self-Administration Protocol for Extended Subcutaneous Thromboprophylaxis in Lower Limb Arthroplasty. The Journal of Bone and Joint Surgery (British Volume), 88, 107-110. http://dx.doi.org/10.1302/0301-620X.88B1.17003
|
[19]
|
Le Gall, C., Jacques, E., Medjebeur, C., Darques, L., Briand, F., Haddad, J., et al. (2006) Low Molecular Weight Heparin Self-Injection Training: Assessment of Feasibility, Tolerance and Economic Analysis in Emergency Departments. European Journal of Emergency Medicine, 13, 264-269. http://dx.doi.org/10.1097/00063110-200610000-00004
|
[20]
|
Piazza, G., Nguyen, T.N., Morrison, R., Cios, D., Hohlfelder, B., Fanikos, J., et al. (2012) Patient Education Program for Venous Thromboembolism Prevention in Hospitalized Patients. The American Journal of Medicine, 125, 258-264. http://dx.doi.org/10.1016/j.amjmed.2011.09.012
|
[21]
|
Urbaniak, G.C. and Plous, S. (2007) Research Randomizer (Version 3.0). Computer Software. http://www.randomizer.org/
|
[22]
|
Zaybak, A. and Khorshid, L. (2008) A Study on the Effect of the Duration of Subcutaneous Heparin Injection on Bruising and Pain. Journal of Clinical Nursing, 17, 378-385.
|
[23]
|
Chan, H. (2001) Effects of Injection Duration on Site-Pain Intensity and Bruising Associated with Subcutaneous Heparin. Journal of Advanced Nursing, 35, 882-892. http://dx.doi.org/10.1046/j.1365-2648.2001.01925.x
|
[24]
|
Balci Akpinar, R. and Celebioglu, A. (2008) Effect of Injection Duration on Bruising Associated with Subcutaneous Heparin: A Quasi-Experimental within-Subject Design. International Journal of Nursing Studies, 45, 812-817. http://dx.doi.org/10.1016/j.ijnurstu.2007.02.005
|
[25]
|
Palese, A., Aidone, E., Dante, A. and Pea, F. (2013) Occurrence and Extent of Bruising According to Duration of Administration of Subcutaneous Low-Molecular-Weight Heparin: A Quasi-Experimental Case-Crossover Study. Journal of Cardiovascular Nursing, 28, 473-482. http://dx.doi.org/10.1097/JCN.0b013e3182578b87
|
[26]
|
Harrison, L., McGinnis, J., Crowther, M., Ginsberg, J. and Hirsh, J. (1998) Assessment of Outpatient Treatment of Deep-Vein Thrombosis with Low-Molecular-Weight Heparin. Archives of Internal Medicine, 158, 2001-2003. http://dx.doi.org/10.1001/archinte.158.18.2001
|
[27]
|
Deakin, D.E., Mishreki, A., Aslam, N. and Docker, C. (2010) Patient Compliance with Extended Low Molecular Weight Heparin Injections Following Hip and Knee Arthroplasty. Hip International, 20, 555-558.
|
[28]
|
Rubenacker, S., Kaiser, J. and Guschmann, M. (2013) Compliance of Patients Undergoing Thromboprophylaxis with Enoxaparin: The Comfort Study. Der Chirurg, 84, 235-242.
|
[29]
|
Karlinski, M., Stolarczyk, A., Siuda, M. and Ziolkowski, M. (2006) Compliance with Low Molecular Weight Heparin in Ambulatory Orthopedic Patients. Ortopedia Traumatologia Rehabilitacja, 8, 633-638.
|
[30]
|
Bergqvist, D., Arcelus, J.I. and Felicissimo, P. (2012) Post-Discharge Compliance to Venous Thromboembolism Prophylaxis in High-Risk Orthopaedic Surgery: Results from the Ethos Registry. Thrombosis and Haemostasis, 107, 280-287. http://dx.doi.org/10.1160/TH11-07-0464
|
[31]
|
Wilke, T., Moock, J., Muller, S., Pfannkuche, M. and Kurth, A. (2010) Nonadherence in Outpatient Thrombosis Prophylaxis with Low Molecular Weight Heparins after Major Orthopaedic Surgery. Clinical Orthopaedics and Related Research, 468, 2437-2453. http://dx.doi.org/10.1007/s11999-010-1306-8
|
[32]
|
Sackett, D.L. and Snow, J.C. (1979) The Magnitude of Compliance and Non Compliance. In: Haynes, R.B., Taylor, D.W. and Sackett, D.L., Eds., Compliance in Health Care, Johns Hopkins University Press, Baltimore, 11-22.
|
[33]
|
Horne, R. and Weinman, J. (1999) Patients’ Beliefs about Prescribed Medicines and Their Role in Adherence to Treatment in Chronic Physical Illness. Journal of Psychosomatic Research, 47, 555-567. http://dx.doi.org/10.1016/S0022-3999(99)00057-4
|
[34]
|
Lebel, B., Malherbe, M., Gouzy, S., Parienti, J.J., Dutheil, J.J., Barrellier, M.T., et al. (2012) Oral Thromboprophylaxis Following Total Hip Replacement: The Issue of Compliance. Orthopaedics and Traumatology: Surgery and Research, 98, 186-192.
|
[35]
|
Quante, M., Thate-Waschke, I. and Schofer, M. (2012) What Are the Reasons for Patient Preference? A Comparison between Oral and Subcutaneous Administration. Zeitschrift für Orthopädie und Unfallchirurgie, 150, 397-403.
|
[36]
|
Wilke, T. (2009) Patient Preferences for an Oral Anticoagulant after Major Orthopedic Surgery: Results of a German Survey. Patient, 2, 39-49. http://dx.doi.org/10.2165/01312067-200902010-00005
|
[37]
|
Weitz, J.I., Eikelboom, J.W. and Samama, M.M. (2012) New Antithrombotic Drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed.: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141, e120S-e151S.
|
[38]
|
Treasure, T. (2011) Venous Thromboembolism—Reducing the Risk. NICE Guideline. http://www.nice.org.uk/guidance/cg92
|
[39]
|
Turner, A.P., Williams, R.M., Sloan, A.P. and Haselkorn, J.K. (2009) Injection Anxiety Remains a Long-Term Barrier to Medication Adherence in Multiple Sclerosis. Rehabilitation Psychology, 54, 116-121. http://dx.doi.org/10.1037/a0014460
|